Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 1 April 2025 30 April 2026 30 April 2026 16357693 N Walsh iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16357693 2025-03-31 16357693 2026-04-30 16357693 2025-04-01 2026-04-30 16357693 frs-core:CurrentFinancialInstruments 2026-04-30 16357693 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-04-30 16357693 frs-bus:FilletedAccounts 2025-04-01 2026-04-30 16357693 frs-bus:Micro-entities 2025-04-01 2026-04-30 16357693 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-04-30 16357693 frs-bus:Director1 2025-04-01 2026-04-30
Registered number: 16357693
Maeve Health Ltd
Unaudited Financial Statements
For the Period 1 April 2025 to 30 April 2026
Coman & Co Ltd
Balance Sheet
Registered number: 16357693
30 April 2026
£
Fixed assets 1,260
Current assets 7,788
Creditors: Amounts Falling Due Within One Year (7,055 )
NET CURRENT ASSETS 733
TOTAL ASSETS LESS CURRENT LIABILITIES 1,993
Accruals and deferred income (582 )
NET ASSETS 1,411
CAPITAL AND RESERVES 1,411

Notes

1. General Information
Maeve Health Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16357693 . The registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
N Walsh
Director
19 August 2026